the report called this “one of the most significant perils to humans resulting from human activity.”
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
"i can't think of anything else where we have done that medically," van den veyver said.
.